Physician profile
Jagdeep Singh
NPI 1396907309
$1,852.92
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $262 · 2020: $186 · 2021: $155 · 2022: $354 · 2023: $350 · 2024: $547.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $897.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $896.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $281.96 | 2023-2024 | Watchman Flx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $250.00 | 2019-2023 | Jardiance |
| Medtronic Vascular, INC. | $185.78 | 2020 | |
| Biotronik INC. | $181.43 | 2024 | Acticor 7 Vr-T Dx |
| Medtronic, INC. | $169.21 | 2022 | |
| Novartis Pharmaceuticals Corporation | $167.49 | 2019-2024 | |
| Novo Nordisk INC | $137.74 | 2024 | Wegovy |
| Abbott Laboratories | $137.57 | 2022 | |
| Janssen Pharmaceuticals, INC | $124.97 | 2021 | |
| Kestra Medical Technology Services, INC. | $89.04 | 2023 | Assure Wcd |
| Medicomp INC | $46.76 | 2022 | |
| Esperion Therapeutics, INC. | $41.42 | 2024 | Nexletol |
| Kiniksa Pharmaceuticals International, Plc | $20.74 | 2024 | Arcalyst |
| Althera Pharmaceuticals LLC | $18.81 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jagdeep Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.